Cargando…
Targeting the Serotonin 5-HT(7) Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date
The 5-HT(7) (5-hydroxytryptamine 7, serotonin 7) receptor is one of the most recently identified members of the serotonin receptor family. Pharmacological tools, including selective antagonists and, more recently, agonists, along with 5-HT(7) receptor (5-HT(7)R) knock-out mice have revealed the invo...
Autor principal: | Nikiforuk, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555343/ https://www.ncbi.nlm.nih.gov/pubmed/25721336 http://dx.doi.org/10.1007/s40263-015-0236-0 |
Ejemplares similares
-
The European Innovative Medicines Initiative: Progress to Date
por: Faure, Jean-Emmanuel, et al.
Publicado: (2018) -
Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
por: Lee, Jieon, et al.
Publicado: (2021) -
Perispinal Delivery of CNS Drugs
por: Tobinick, Edward Lewis
Publicado: (2016) -
Therapeutic and Prophylactic Potential of Small Interfering RNAs against Severe Acute Respiratory Syndrome: Progress to Date
por: Chang, Zhijie, et al.
Publicado: (2012) -
Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats
por: Fijał, Katarzyna, et al.
Publicado: (2013)